End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.63 USD | -0.89% | +5.47% | -39.16% |
05-09 | Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
- Stock Market
- Equities
- GYRE Stock
- Charts Gyre Therapeutics, Inc.